Aoi W, Ogaya Y, Takami M, Konishi T, Sauchi Y, Park EY, Wada S, Sato K, Higashi A
Common early experiences include: Reduced appetite : Many people notice decreased hunger and earlier satiety during meals within days of the first injection or dose Mild gastrointestinal symptoms : Nausea (affecting 2040% of patients), occasional vomiting, or changes in bowel habits are usually mild and transient Injection site reactions : Minor redness, itching, or discomfort at injection sites is common but typically resolves quickly Fatigue : Some individuals report feeling more tired initially as their body adjusts to reduced calorie intake By weeks 24 , appetite suppression typically becomes more pronounced, and patients often find it easier to adhere to portion control and dietary modifications
It can help you set realistic goals before starting treatment with The Care Pharmacy
Because the treatment bypasses the digestive system, it reduces the likelihood of stomach discomfort or other gastrointestinal side effects
For compounded tirzepatide at typical concentrations (5 mg/mL or 10 mg/mL), a 31G needle handles flow well and minimizes injection discomfort